healthcare News
Alnylam, Roche Advance Hypertension Drug to Pivotal Phase 3 Trial
Zilebesiran, a twice-yearly injection, will be tested in 11,000 high-risk patients following promising mid-stage results.
Amarin Surges on Positive VASCEPA Trial Data
New analyses from the REDUCE-IT trial show a 9% reduction in hospitalizations, bolstering the drug's profile amid ongoing generic competition.
BridgeBio Drug Acoramidis Shows 44% Cut in Heart-Related Deaths
Long-term study data presented at a major cardiology conference reinforces the drug's potential in treating a rare heart condition.
MSP Recovery Secures $55M Lifeline at a Heavy Cost to Shareholders
Financing deal carries risk of 46% equity dilution, coupled with a 1-for-7 reverse stock split to maintain Nasdaq listing.
Cytokinetics Drug Bests Standard Care in Heart Study
Aficamten proves superior to metoprolol for hypertrophic cardiomyopathy, positioning the drug for a potential shift in treatment standards.
InflaRx Stock Surges on EU Approval for Sepsis Drug
Shares soared over 36% after the European Commission authorized GOHIBIC for treating critically ill COVID-19 patients.
Sanofi Wins FDA Approval for New Blood Disorder Drug Wayrilz
First-in-class BTK inhibitor for immune thrombocytopenia (ITP) projected to achieve multi-billion dollar peak sales.
Biogen, Eisai Win FDA Nod for At-Home Alzheimer's Drug Leqembi Iqlik
The new subcutaneous autoinjector offers a more convenient weekly maintenance option for patients after initial IV treatment.